News
Novo Nordisk (NVO) stock draws mixed views from Wall Street analysts after the obesity drugmaker cut its 2025 outlook for the ...
Shares of Hims Hers Health Inc (NYSE:HIMS) fell more than 3% early Tuesday before paring losses to around 0.2% in afternoon trade, after rising legal risks and a data disclosure drove swings in ...
storage.googleapis.com on MSN1d
Novo Nordisk (NVO) Just Lost $100B and Blamed HIMSNovo Nordisk ($NVO) lost nearly $100 billion in market cap in one session and pointed fingers at Hims & Hers Health ($HIMS) as the reason. Shay calls out the absurdity of a $300B company blaming a ...
17h
Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...
Hims & Hers remains a compelling long-term play, with a resilient subscription-driven model, 85%+ retention, and 2.4 million ...
Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.
Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two months ago.
Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Novo Nordisk is ending its newly started relationship with a telehealth service, Hims & Hers, to provide direct access to a popular GLP-1 weight loss drug, Wegovy, claiming it has engaged in ...
Novo Nordisk launched the partnership through CenterWell, Humana's (HUM) mail-order pharmacy, which would dispense the drugs prescribed by three telehealth providers — one of which was Hims & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback